Research Points to Effectiveness of UC-II Collagen Ingredient

UC Davis researcher, Siba Raychaudhuri, M.D., presented a portfolio of joint-health research on UC-II®, including published clinical data, at the Federation of Clinical Immunology Societies (FOCIS) 2010 meeting in Boston, June 24–27th. Dr. Raychaudhuri, a rheumatologist at the Department of Medicine, University of California Davis, is also the corresponding author of a published clinical study demonstrating that UC-II® was more than twice as effective as glucosamine + chondroitin.

Researchers and clinicians from around the world attend the FOCIS annual meeting to draw pertinent information and learn about new science and breakthroughs regarding human health and to share expertise to build a better and faster understanding on various ways to address inflammatory and autoimmune diseases. Dr. Raychaudhuri’s FOCIS presentation entitled, “Undenatured Type II Collagen (UC-II®) in the Treatment of Osteoarthritis” addressed one of the hottest topics in the industry, joint-health support.

“Not only is the clinical data on UC-II® impressive, it also works in quite a unique way to inhibit joint cartilage damage, allowing the body to rebuild healthy joints,” said Dr. Raychaudhuri. “UC-II® contains undentaured type II collagen, which reportedly aids in reducing the destruction of collagen within the joints, helps to reduce inflammation in the joints and improves joint flexibility.”

UC-II® brand undenatured type II collagen is derived from chicken sternum cartilage for joint health by patented, low-temperature, non-enzymatic manufacturing processes that ensure the presence of active epitopes—giving UC-II® its unique mechanism of action and increased clinical efficacy over glucosamine + chondroitin. With as many as 46 million people suffering from doctor-diagnosed arthritis and a projected 67 million by 2030, InterHealth is leading the way in finding natural, safe, innovative ways to support joint health and improved quality of life for millions of people.

About InterHealth Nutraceuticals, Inc.

InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company’s products include UC-II®, an all-natural ingredient for joint health; Super CitriMax®, weight management and satiety ingredient; and ChromeMate®, a niacin-bound chromium product that addresses both blood sugar and cardiovascular health. In addition, InterHealth offers Aller-7®, OptiBerry®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.